← All Sponsors
SPONSOR

Hangzhou GluBio Pharmaceutical Co., Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Non-Hodgkin Lymphoma
NCT06219356 Phase 1
Recruiting

A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

Non-Hodgkin Lymphoma
China View Trial →